UKRI-4970 Harwell Health Screening Service

The UK Research & Innovation (UKRI), a central government public authority based in Swindon, Wiltshire, has completed its procurement process for the "UKRI-4970 Harwell Health Screening Service" contract, which involves providing a health screening service for MRC Harwell over a period of two years. The contract, valued at £420,648 (gross), was awarded to Fera Science Ltd, a large supplier located in York. This open procedure procurement adheres to the legal requirements of the UK Procurement Act 2023/54 and is set to start on 8th January 2026, potentially extending until 7th January 2031, subject to renewals.

The primary category for this service is research and pathology services, and the contract has been published under the Global Procurement Agreement (GPA). The contract signing was completed on 7th November 2025. This tender provides substantial opportunities for businesses specialising in research and pathology services, particularly those capable of meeting the technical and quality demands of a public sector health screening service.

Organisations looking to expand into governmental contracts or increase their footprint in public health services will find this procurement advantageous, especially given its potential for renewals and the significance of UKRI as a governmental client. The awarded supplier, Fera Science Ltd, has demonstrated capability and competitiveness in the procurement process, with UKRI valuing both price and technical expertise, suggesting a favourable procurement environment for businesses equipped with robust industry knowledge and service quality. Small and medium enterprises (SMEs) and those with expertise in pathology services could greatly benefit from leveraging the experience and insights gained from such tenders for future opportunities.